Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

Emily Nickles, Bhushan Dharmadhikari, Yating Li, Robert J. Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Lingzhi Wang, Yvonne Ang, Yugarajah Asokumaran,

Cancer Immunology Immunotherapy · 2021 · 28 citations · 42 references

DOIFull text

Open access

Concepts

References

42